Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon-alpha therapy].

A Tojo1

  • 1Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Interferon-alpha (IFN alpha) therapy offers a better prognosis for chronic myeloid leukemia (CML) patients ineligible for stem cell transplants. While effective, its immune-mediated mechanisms against CML remain under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between GvHD and nivolumab in the FDA adverse event reporting system.

Bone marrow transplantation·2017
Same author

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.

Oncogene·2016
Same author

Clearance of blasts from peripheral blood during induction chemotherapy using exponential decay model predicts complete remission and long-term survival in adult acute myeloid leukemia.

International journal of laboratory hematology·2014
Same author

Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking.

Leukemia·2014
Same author

Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.

Bone marrow transplantation·2014
Same author

Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations.

Transplant infectious disease : an official journal of the Transplantation Society·2013

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Context:

  • Chronic myeloid leukemia (CML) management for patients ineligible for allogeneic stem cell transplantation.
  • Interferon-alpha (IFN alpha) as a therapeutic option, often combined with Ara-C.
  • Conventional chemotherapy as a less favorable alternative.

Purpose:

  • To explore the therapeutic potential of IFN alpha in CML.
  • To understand the underlying mechanisms of IFN alpha's efficacy.
  • To investigate the role of immune-mediated responses in IFN alpha's anti-CML activity.

Summary:

  • IFN alpha therapy, with or without Ara-C, provides a better prognosis for CML patients unsuitable for stem cell transplantation compared to conventional chemotherapy.
  • A subset of CML patients (approximately 20%) achieve complete cytogenetic response with IFN alpha, even with persistent minimal residual disease.

Related Experiment Videos

  • The precise mechanisms of IFN alpha's action against CML are not fully elucidated, but immune-mediated pathways are hypothesized to contribute.

    • Impact:

    • IFN alpha represents a valuable treatment strategy for a specific CML patient cohort.
    • Further research into immune-mediated mechanisms could lead to improved CML therapies.
    • Understanding treatment response variations can guide personalized CML management.